METHODS: In 2014, data were collected from a 1% sample of reports made to the FDA from 2000-2014 regarding mesh for POP and SUI. The data included manufacturer, device, reporter, complainant diagnosis, and adverse events. The same 1% sample was reviewed again using the same methods in June of 2018 and edits made to each entry were analyzed.
INTRODUCTION AND OBJECTIVES:
The need for long-term follow up data in female patients undergoing surgery for stress urinary incontinence (SUI) has been repeatedly highlighted by Cochrane reviews and the FDA. This is especially relevant in the current climate of controversy over the safety of mesh-related products. We aimed to assess the subjective long-term outcomes of patients who had undergone SUI surgery at our institution in this real-world study.
METHODS: All female patients who underwent SUI surgery at one institution from January 2011 to December 2016 were identified and sent a 5-item self-administered postal questionnaire. Results were analysed using GraphPad Prism 6.0.
RESULTS: Questionnaires were returned by 364 of 570 patients identified (64% response rate), with a median age of 51 (range 17e84) and mean follow up of 54 months. The majority of respondents underwent TOT insertion (79%), followed by TVT (17%), autologous sling (2%) and Burch colposuspension (2%). 94% of procedures were primary (6% revision). Two-thirds underwent pre-procedure urodynamics. 63/364 (17%) were identified to have a concurrent pelvic organ prolapse (POP) and were treated surgically if symptomatic.
69% of patients described their SUI as much or very much better (73% TOT, 53% TVT). A significantly greater proportion of patients undergoing TVT insertion did so as revision surgery when compared to TOT insertion (p[0.0037). Overall, 55% described an improvement/cure in their overactive bladder symptoms, while 8% said they were worse. A quarter complained of new voiding difficulty (23% TOT, 27% TVT), with 9% requiring intermittent self-catheterisation. 52% declared no post-operative problems, with the remainder reporting UTI (20%), dyspareunia (13%), pelvic pain (12%) and new POP (5%). Ultimately, 7% stated that they had required further surgery, the majority of which was for recurrent SUI. Specifically, 0.8% (3/364) required surgery for tape erosion (all vaginal).
CONCLUSIONS: This study is one of the largest cohorts to report patient-centred real-world outcomes with over 4 year follow up. Our results demonstrate a wane in efficacy of surgery over time, while quantifying the longer-term incidence of complications and the need for further surgery. All surgeons performing surgical procedures for SUI should audit their long-term outcomes in order to accurately counsel patients considering SUI surgery and aid in their decisionmaking.
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PD06-04 IMPACT OF FELLOWSHIP TRAINING ON HOSPITAL DISCHARGE DATA FOR WOMEN UNDERGOING URINARY INCONTINENCE PROCEDURESa
Garrett Smith*, Natasha Ginzburg, Syracuse, NY INTRODUCTION AND OBJECTIVES: Urinary incontinence is a prevalent condition that is becoming recognized in more women regardless of the presence of traditional risk factors. Female Pelvic Medicine & Reconstructive Surgery (FPMRS) is a subspecialty of urologists and gynecologists with expertise in the management of pelvic floor disorders, including refractory incontinence. We hypothesized that patients hospitalized after incontinence procedures would have different characteristics based on the level of training of their surgeon. FPMRS surgeons may treat more complex patients in metropolitan areas, and this may be associated with higher costs and length of hospitalization.
METHODS: New York State Statewide Planning and Research Cooperative System (SPARCS) inpatient de-identified datasets were queried for women who underwent genitourinary incontinence procedures from 2009 to 2016. Descriptive statistics using chi-square tests were performed to compare FPMRS-trained surgeons to non-FPMRS surgeons. Age, race, length-of-stay (LOS), hospital service area, and cost were assessed, as was All Patient Refined severity of illness (classified as major, moderate, mild), which calculates the impact of comorbid diseases on a patient's overall health.
RESULTS: Patients undergoing incontinence procedures did not differ by age (p[0.545), however they did differ by race (p[0.001), with FPMRS surgeons operating on more black women (10.3%) and fewer white women (67.0%) compared to non-fellowship trained surgeons (8.2%,75.0%). LOS did not differ between groups (p[0.276). Severity of overall patient illness did not differ significantly based on training (p[0.193) , however 31.0% of moderately complex patients were operated on by FPMRS-trained providers compared to 27.6% in the non-FPMRS group. Fellowship-trained surgeons concentrated near large cities, with 68.3% of all incontinence procedures in Manhattan performed by FPMRS-trained surgeons, versus 39.6% in the Finger Lakes region or 4.5% in Western NY, for instance. Finally, cost differed significantly between groups (p[0.000), with 75.1% of non-FPMRS surgeons having total costs under $7,500 versus 53.7% under such cost in the FPMRS-trained group. Insurance payer did not differ by provider type (p[0.157).
CONCLUSIONS: There was a geographical concentration of practice for FPMRS-trained surgeons in metropolitan areas, presumably at academic centers. They treated a more diverse demographic of patients, but insurance type did not differ. Cost was expectedly higher, however this was not influenced by age or reported severity of illness,
